These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34326345)

  • 21. Untangling Nonerosive Reflux Disease From Functional Heartburn.
    Patel D; Fass R; Vaezi M
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1314-1326. PubMed ID: 32246998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease.
    Malagelada JR
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():43-8. PubMed ID: 14725578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
    DeVault KR
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: approaches to the long-term management of adults with GERD-proton pump inhibitor therapy, laparoscopic fundoplication or endoscopic therapy?
    Freston JW; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():35-42. PubMed ID: 14725577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.
    Cicala M; Emerenziani S; Guarino MP; Ribolsi M
    World J Gastroenterol; 2013 Oct; 19(39):6529-35. PubMed ID: 24151377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results.
    Galmiche JP
    Drugs; 2006; 66 Suppl 1():7-13; discussion 29-33. PubMed ID: 16869343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
    Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].
    Simon M; Zerbib F
    Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
    Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
    World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroesophageal reflux disease.
    Fock KM; Poh CH
    J Gastroenterol; 2010 Aug; 45(8):808-15. PubMed ID: 20585811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory gastro-oesophageal reflux disease: diagnosis and management.
    Liu JJ; Saltzman JR
    Drugs; 2009 Oct; 69(14):1935-44. PubMed ID: 19747009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroesophageal reflux disease: key messages for clinicians.
    Saracco M; Savarino V; Bodini G; Saracco GM; Pellicano R
    Minerva Gastroenterol (Torino); 2021 Dec; 67(4):390-403. PubMed ID: 33103406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroesophageal Reflux Disease.
    Kellerman R; Kintanar T
    Prim Care; 2017 Dec; 44(4):561-573. PubMed ID: 29132520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: epidemiology and management of gastro-oesophageal reflux in children.
    Gold BD
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():22-7. PubMed ID: 14725575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AGA Clinical Practice Update on Functional Heartburn: Expert Review.
    Fass R; Zerbib F; Gyawali CP
    Gastroenterology; 2020 Jun; 158(8):2286-2293. PubMed ID: 32017911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory gastroesophageal reflux disease.
    Moraes-Filho JP
    Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
    Armstrong D; Marshall JK; Chiba N; Enns R; Fallone CA; Fass R; Hollingworth R; Hunt RH; Kahrilas PJ; Mayrand S; Moayyedi P; Paterson WG; Sadowski D; van Zanten SJ;
    Can J Gastroenterol; 2005 Jan; 19(1):15-35. PubMed ID: 15685294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current understanding of the mechanisms of gastro-oesophageal reflux disease.
    Orlando RC
    Drugs; 2006; 66 Suppl 1():1-5; discussion 29-33. PubMed ID: 16869342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: diagnosis and clinical investigation of gastro-oesophageal reflux disease: a European view.
    Heading RC
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():9-13. PubMed ID: 15575865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.